Trials / Unknown
UnknownNCT03173183
Treatment of Functional Dyspepsia With Genuine Regional Rhizoma Atractylodis
Clinical Research on Treatment of Functional Dyspepsia With Genuine Regional Rhizoma Atractylodis: a Randomized Double-blind Placebo Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- China Academy of Chinese Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized double-blind placebo controlled trial aim to compare the efficiency of genuine regional and non-genuine regional Rhizoma Atractylodis in treating functional dyspepsia. This study will also observe the clinical safety of genuine regional Rhizoma Atractylodis.The trial will be conducted in Xiyuan Hospital of China Academy of Chinese Medicine Sciences and Dongzhimen Hospital of Beijing University of Chinese Medicine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | genuine regional Rhizoma Atractylodis (Maozhu granule) | Maozhu granule, 9g per bag, manufactured by Guangdong Yifang Pharmaceutical Co., Ltd. Luozhu granule, 9g per bag, manufactured by Guangdong Yifang Pharmaceutical Co., Ltd. Simulants (granule), 9g per bag, manufactured by Guangdong Yifang Pharmaceutical Group Co., Ltd. |
Timeline
- Start date
- 2017-08-01
- Primary completion
- 2018-08-01
- Completion
- 2018-08-01
- First posted
- 2017-06-01
- Last updated
- 2017-06-01
Source: ClinicalTrials.gov record NCT03173183. Inclusion in this directory is not an endorsement.